02/05/2015 - 11:42am

In this issue, DSN looks at another three hot spot issues identified by PwC’s HRI that will help define how health care is provided in 2015.

02/05/2015 - 11:16am

HDMA recognized four members of Congress with the Association’s Rx Safety and Healthcare Leadership Award.

02/05/2015 - 10:55am

The Walgreens API team announced the availability of the Healthcare Clinic Scheduler Application Program Interface.

 

02/05/2015 - 10:29am

Pfizer has entered into a definitive merger agreement to acquire Hospira.

 

02/03/2015 - 3:32pm

Camber Pharmaceuticals on Tuesday announced the launch of rizatriptan benzoate tablets in 5- and 10-mg dosage strengths. 

 

02/03/2015 - 3:25pm

Zogenix last week announced that the Food and Drug Administration approved a new formulation of the company's Zohydro ER (hydrocodone bitartrate) extended-release capsules, CII.

02/03/2015 - 3:06pm

Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Co. on Monday announced that the Food and Drug Administration has approved Glyxambi (empagliflozin/linagliptin) tablets. 

 

02/03/2015 - 2:38pm

Afrezza, an inhaled insulin powder, is now available by prescription in U.S. retail pharmacies, Sanofi and MannKind Corp. announced. The drug is approved by the Food and Drug Administration to control high blood sugar in adults who have type 1 and type 2 diabetes.

 

02/03/2015 - 2:25pm

Diplomat Pharmacy announced Monday that it has earned the Verified Internet Pharmacy Practice Sites seal of approval from the National Association of Boards of Pharmacy.